Literature DB >> 23255039

A road map for patients with imminent end-stage renal disease.

Felix Burkhalter1, Juerg Steiger, Michael Dickenmann.   

Abstract

Chronic kidney disease (CKD) represents a relevant medical and financial burden. More than 5% of the population suffers from CKD. There should be an accurately timed evaluation of best renal replacement therapy in all patients with CKD. Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Living donated kidney transplantation offers the best results and should be evaluated in every patient suitable for transplantation. Haemodialysis and peritoneal dialysis are equally effective treatment options in patients not suitable for transplantation and should be individually evaluated. Conservative treatment, avoiding a dialysis treatment, can also be an option. Close cooperation of the general practitioner with a nephrologist improves patient management and helps to lower costs.

Entities:  

Mesh:

Year:  2012        PMID: 23255039     DOI: 10.4414/smw.2012.13713

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  1 in total

1.  C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients.

Authors:  Dominik Steubl; Stefan Hettwer; Pius Dahinden; Peter Luppa; Ina-Christine Rondak; Claudia Regenbogen; Konrad F Stock; Lutz Renders; Uwe Heemann; Marcel Roos
Journal:  Int Urol Nephrol       Date:  2014-10-29       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.